2 weeks Ago
Standard BioTools ( NASDAQ: LAB ) is scheduled to announce Q3 earnings results on Wednesday, October 30th, after market close. The consensus EPS Estimate is -$0.07 and the consensus Revenue Estimate is $41M (+61.
7% Y/Y). Over the last 1 year, LAB has beaten.
